Current Urology Reports

, Volume 5, Issue 1, pp 65–72 | Cite as

Treatment of adrenocortical carcinoma: Contemporary outcomes

  • David Y. T. Chen
  • R. Ernest Sosa
  • Douglas S. Scherr
Article

Abstract

Adrenocortical carcinoma is a rare cancer that historically has been associated with poor outcome. Throughout the past decades, growing experience has allowed better understanding of the natural history and optimal management of this cancer. Advances in imaging and aggressive surgical therapy have raised the outlook for recently diagnosed patients. Further improvements in survival will require more effective systemic therapy.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Icard P, Goudet P, Charpenay C, et al.: Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 2001, 25:891–897.PubMedCrossRefGoogle Scholar
  2. 2.
    Kendrick ML, Lloyd R, Erickson L, et al.: Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 2001, 136:543–549.PubMedCrossRefGoogle Scholar
  3. 3.
    National Cancer Institute: Third National Cancer Survey Incidence Data. Bethesda, MD: National Cancer Institute; 1975:785–787.Google Scholar
  4. 4.
    Wooten MD, King DK: Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature. Cancer 1993, 72:3145–3155.PubMedCrossRefGoogle Scholar
  5. 5.
    Bukowski RM, Klein EA: Adrenal neoplasms. In Comprehensive Textbook of Genitourinary Oncology. Edited by Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS. Philadelphia: Lippincott, Williams & Wilkins; 2000:1073–1101.Google Scholar
  6. 6.
    Wajchenberg BL, Pereira MA, Medonca BB, et al.: Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000, 88:711–736.PubMedCrossRefGoogle Scholar
  7. 7.
    Brennan MF: Adrenocortical carcinoma. CA Cancer J Clin 1987, 37:348–365.PubMedGoogle Scholar
  8. 8.
    King DR, Lack EE: Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 1979, 44:239–244.PubMedCrossRefGoogle Scholar
  9. 9.
    Hogan TF, Gilchrist KW, Westring DW, Citrin DL: A clinical and pathological study of adrenocortical carcinoma: therapeutic implications. Cancer 1980, 45:2880–2883.PubMedCrossRefGoogle Scholar
  10. 10.
    Karakousis CP, Rao V, Moore, R: Adrenal adenocarcinomas: histologic grading survival. J Surg Oncol 1985, 29:105–111.PubMedCrossRefGoogle Scholar
  11. 11.
    Bodie B, Novick AC, Pontes, JE, et al.: The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol 1989, 141:257–260.PubMedGoogle Scholar
  12. 12.
    Luton JP, Cerda S, Billaud L, et al.: Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990, 322:1195–1201.PubMedCrossRefGoogle Scholar
  13. 13.
    Schulick RD, Brennan MF: Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999, 6:719–726.PubMedCrossRefGoogle Scholar
  14. 14.
    Favia G, Lumachi F, D’Amico DF: Adrenocortical carcinoma: Is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World J Surg 2001, 25:735–738.PubMedCrossRefGoogle Scholar
  15. 15.
    Mantero F, Terzolo M, Arnaldi G, et al.: A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000, 85:637–644. Large review of the clinical significance of the incidental adrenal mass with probable findings and outcomes described.PubMedCrossRefGoogle Scholar
  16. 16.
    Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, et al.: Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 1997,46:29–37.CrossRefGoogle Scholar
  17. 17.
    Bulow B, Ahren B, Swedish Research Council Study Group of Endocrine Abdominal Tumours: Adrenal incidentaloma: experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 2002, 252:239–246.PubMedCrossRefGoogle Scholar
  18. 18.
    MacFarlane DA: Cancer of the adrenal cortex: the natural history, prognosis, and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 1958, 23:155–186.PubMedGoogle Scholar
  19. 19.
    Norton JA, Le HN: Adrenal tumors. In Cancer: Principles and Practice of Oncology. Edited by DeVita VT, Hellman S, Rosenberg SA. Philadelphia: Lippincott, Williams & Wilkins; 2001:1770–1788.Google Scholar
  20. 20.
    Venkatesh S, Hickey RC, Sellin RV, et al.: Adrenal cortical carcinoma. Cancer 1989,64:765–769.PubMedCrossRefGoogle Scholar
  21. 21.
    Grondal S, Cedermark B, Eriksson B, et al.: Adrenocortical carcinoma: a retrospective study of a rare tumor with a poor prognosis. Eur J Surg Oncol 1990,16:500–506.PubMedGoogle Scholar
  22. 22.
    Soreide JA, Brabrand K, Thoresen SO: Adrenal cortical carcinoma in Norway, 1970–1984. World J Surg 1992, 16:663–668.PubMedCrossRefGoogle Scholar
  23. 23.
    Pommier RF, Brennan MF: An 11-year experience with adrenocortical carcinoma. Surgery 1992, 112:963–970.PubMedGoogle Scholar
  24. 24.
    Zografos GC, Driscoll DL, Karakousis CP, Huben, RP: Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol 1994, 55:160–164.PubMedCrossRefGoogle Scholar
  25. 25.
    Haak HR, Hermans J, de van Velde CJ, et al.: Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 1994, 69:947–951.PubMedGoogle Scholar
  26. 26.
    Bellantone R, Ferrante A, Boscherini M, et al.: Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 1997, 122:1218–1218.CrossRefGoogle Scholar
  27. 27.
    Eddy RL, Jones AL, Gilliland PF, et al.: Cushing’s syndrome: a prospective study of diagnostic methods. Am J Med 1973, 55:621–630.PubMedCrossRefGoogle Scholar
  28. 28.
    Korobkin M, Francis IR: Imaging of adrenal masses. Urol Clin North Am 1997, 24:603–622.PubMedCrossRefGoogle Scholar
  29. 29.
    Kouriefs C, Mokbel K, Choy C: Is MRI more accurate than CT in estimating the real size of adrenal tumours? Eur J Surg Oncol 2001, 27:487–490.PubMedCrossRefGoogle Scholar
  30. 30.
    Godellas CV, Prinz RA: Surgical approaches to adrenal neoplasms: Laparoscopic versus open adrenalectomy. Surg Oncol Clin North Am 1998, 7:807–817.Google Scholar
  31. 31.
    Wells SA, Merke DP, Cutler GB, et al.: Therapeutic controversy: the role of laparoscopic surgery in adrenal disease. J Clin Endocrinol Metab 1998, 83:3041–3049.PubMedCrossRefGoogle Scholar
  32. 32.
    Gill IS: The case for laparoscopic adrenalectomy. J Urol 2001, 166:429–436.PubMedCrossRefGoogle Scholar
  33. 33.
    Hobart MG, Gill IS, Schweizer D, et al.: Laparoscopic adrenalectomy for large-volume (bd> or = 5 cm) adrenal masses. J Endourol 2000, 14:149–154.PubMedCrossRefGoogle Scholar
  34. 34.
    Kebebew E, Siperstein AE, Clark OH, Duh QY: Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 2002, 137:948–949. Provides strong evidence justifying the laparoscopic approach for malignant adrenal tumors when complete resection is feasible; demonstrates outcome that is comparable with open surgery.PubMedCrossRefGoogle Scholar
  35. 35.
    Bergenstal DM, Hertz R, Lipsett MB, Moy RH: Chemotherapy of adrenocortical cancer with o,p’-DDD. Ann Intern Med 1960, 53:672–684.Google Scholar
  36. 36.
    Boven E, Vermorken JB, vanSlooten H, Pinedo HM: Complete response of metastasized adrenal cortical carcinoma with o,p’-DDD: case report and literature review. Cancer 1984, 55:26–29.CrossRefGoogle Scholar
  37. 37.
    Terzolo M, Pia A, Berruti A, Osella G: Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effect in patients with adrenocortical cancer. J Clin Endocrinol Metab 2000, 85:2234–2238.PubMedCrossRefGoogle Scholar
  38. 38.
    Markoe AM, Serber W, Micaily B, Brady LW: Radiation therapy for adjunctive treatment of adrenal cortical carcinoma. Am J Clin Oncol 1991, 14:170–174.PubMedCrossRefGoogle Scholar
  39. 39.
    Percarpio B, Knowlton AH: Radiation therapy of adrenal cortical carcinoma. Acta Radiol Ther Phys Biol 1976, 15:288–292.PubMedGoogle Scholar
  40. 40.
    Jossart GH, Shibuya K, Gagner M: Laparoscopic cryotherapy of the liver, pancreas, and adrenal gland. Surg Technol Int 2000, 8:195–109.Google Scholar
  41. 41.
    Wood BJ, Abraham J, Hvizda JL, et al.: Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003, 97:554–560.PubMedCrossRefGoogle Scholar
  42. 42.
    Regge D, Balma E, Lasciarrea P, et al.: Interventional radiology of the adrenal glands. Minera Endocrinol 1995, 20:15–26.Google Scholar
  43. 43.
    Tang CK, Gray GF: Adrenocortical neoplasms: prognosis and morphology. Urology 1975, 5:691–695.PubMedCrossRefGoogle Scholar
  44. 44.
    Weiss LM, Medeiros LJ, Vickery AL: Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989, 13:202–206.PubMedCrossRefGoogle Scholar
  45. 45.
    Barnett CC, Varma DG, El-Naggar AK, et al.: Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 2000, 128:973–982.PubMedCrossRefGoogle Scholar
  46. 46.
    Weiss LM: Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984, 8:163–169.PubMedCrossRefGoogle Scholar
  47. 47.
    Stojadinovic A, Ghossein RA, Hoos A, et al.: Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 2002, 4:941–950. A detailed analysis of morphologic and histopathologic characteristics of adrenocortical tumors; it correlates the significance of various parameters to outcome and establishes criteria for stratification of patients into prognostic groups.CrossRefGoogle Scholar
  48. 48.
    Wieneke JA, Thompson LDR, Heffess CS: Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol 2003, 27:867–881. A comprehensive clinical and pathologic characterization of adrenocortical carcinoma in a large pediatric population. This study describes the different behavior of pediatric tumors and proposes prognostic criteria to suggest malignancy.PubMedCrossRefGoogle Scholar
  49. 49.
    Lo CY, van Heerden JA, Soreide JA, et al.: Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg 1996, 84:528–531.CrossRefGoogle Scholar
  50. 50.
    Kim SH, Brennan MF, Russo P, et al.: The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 1998, 82:389–394.PubMedCrossRefGoogle Scholar
  51. 51.
    Lenert JT, Barnett CC, Kudelka AP, et al.: Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 2001, 130:1060–1067.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • David Y. T. Chen
    • 1
  • R. Ernest Sosa
  • Douglas S. Scherr
  1. 1.Department of Urology, New York-Presbyterian HospitalWeill Cornell Medical CenterNew YorkUSA

Personalised recommendations